Jove
Visualize
Contact Us

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
3.6K
Molecular Models02:00

Molecular Models

43.7K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.7K
The Thyroid Gland01:23

The Thyroid Gland

7.6K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.6K
Nursing Code of Ethics01:29

Nursing Code of Ethics

4.5K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.

The Journal of experimental medicine·2025
Same author

Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers.

Current opinion in endocrine and metabolic research·2024
Same author

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.

Thyroid : official journal of the American Thyroid Association·2023
Same author

High-throughput <i>in situ</i> perturbation of metabolite levels in the tumor micro-environment reveals favorable metabolic condition for increased fitness of infiltrated T-cells.

Frontiers in cell and developmental biology·2023
Same author

Case Report of <i>CCDC149-ALK</i> Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.

Thyroid : official journal of the American Thyroid Association·2022
Same author

A Two-Photon Microimaging-Microdevice System for Four-Dimensional Imaging of Local Drug Delivery in Tissues.

International journal of molecular sciences·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.3K

Coding Molecular Determinants of Thyroid Cancer Development and Progression.

Veronica Valvo1, Carmelo Nucera2

  • 1Laboratory of Human Thyroid Cancers Preclinical and Translational Research, Division of Experimental Pathology, Department of Pathology, Cancer Research Institute (CRI), Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215, USA; Department of Pathology, Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215, USA.

Endocrinology and Metabolism Clinics of North America
|February 6, 2019
PubMed
Summary

Thyroid cancer, the most common endocrine malignancy, shows increasing incidence and mortality in advanced stages. Understanding its molecular pathways and genetic alterations is key to developing new treatments and improving patient prognosis.

Keywords:
BRAF(V600E)CDKN2AMicroenvironmentPAX8/PPRγRASThyroid carcinomahTERT

More Related Videos

An Ex vivo Culture System to Study Thyroid Development
08:33

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

12.1K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.0K

Related Experiment Videos

Last Updated: Jan 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.3K
An Ex vivo Culture System to Study Thyroid Development
08:33

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

12.1K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.0K

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Thyroid cancer is the most common endocrine malignancy.
  • Increasing incidence and mortality rates are observed in advanced-stage papillary thyroid cancer.
  • Intracellular signaling pathways play a crucial role in thyroid cancer progression, including clonal evolution, dedifferentiation, metastasis, and drug resistance.

Purpose of the Study:

  • To review the progress in characterizing molecular pathways in thyroid cancer.
  • To highlight the clinical applications of discovered genetic alterations.
  • To emphasize the importance of understanding molecular pathway interplay for therapeutic development.

Main Methods:

  • Literature review and analysis of recent research findings.
  • Characterization of genetic alterations such as mutations (BRAF, hTERT), translocations, deletions (9p), and copy-number gain (1q).
  • Exploration of intracellular signaling pathways involved in thyroid cancer initiation and progression.

Main Results:

  • Significant progress has been made in understanding the molecular basis of thyroid cancer.
  • Specific genetic alterations (BRAF, hTERT mutations, 9p deletions, 1q copy-number gain) have been identified.
  • Molecular pathways are critical drivers of tumor progression and therapeutic resistance.

Conclusions:

  • Understanding the interplay of molecular pathways is essential for advancing thyroid cancer treatment.
  • New therapeutic strategies can be developed based on insights into genetic alterations and signaling pathways.
  • Improved prognosis for thyroid cancer patients can be achieved through targeted molecular therapies.